Reunert Ltd buy krebskrebs
Start price
30.11.20
/
50%
€2.14
Target price
30.11.21
€3.00
Performance (%)
22.43%
End price
01.12.21
€2.62
Summary
This prediction ended on 01.12.21 with a price of €2.62. The prediction had a final performance of 22.43%. A total of €0.11 was paid as dividends for this prediction. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reunert Ltd | -2.649% | -2.649% | -24.615% | 8.889% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by krebskrebs for this prediction
In the thread Reunert Ltd diskutieren
In the thread Trading Reunert Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten